Market Place
Sourcing Support
Alzinova doses first patient in extension part of Phase Ib ALZ-101 trial
30 May 2023 //
CLINICAL TRIALS ARENA
Alzinova announces new positive safety review of its phase 1b study
08 Sep 2022 //
PHARMABIZ
Alzinova announces positive safety review and continues PIb study in Alzheimer`s
28 Apr 2022 //
PRNEWSWIRE
Alzinova improves manufacturing process of ALZ-101 to meet phase 2 requirements
30 Mar 2022 //
PRNEWSWIRE
Alzinova completes humanisation work and selects lead candidate for ALZ-201
20 Jan 2022 //
BIOSPACE
First patient recruited into Alzinova`s phase 1b clinical study ALZ-101
29 Oct 2021 //
PRNEWSWIRE
Alzinova receives approval to start first clinical study with ALZ-101 vaccine
30 Sep 2021 //
PRNEWSWIRE
Alzinova presents preclinical data on Alzheimer disease candidates
27 Jul 2021 //
PRNEWSWIRE
Alzinova presents preclinical data on Alzheimer disease candidates
27 Jul 2021 //
PRNEWSWIRE
Alzinova preclinical data on Alzheimer disease candidates at the AAIC conference
26 Jul 2021 //
PRNEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.